- Advertise
- About OncLive
- Editorial Board
- CancerNetwork.com
- CGTlive.com
- CureToday.com
- OncNursingNews.com
- TargetedOnc.com
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute (OSUCCC - James) | Strategic Alliance Partners
Latest from The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute (OSUCCC - James)
Dr. Salani on Patient Selection for Primary Debulking Surgery in Ovarian Cancer
January 25, 2020
Video
Ritu Salani, MD, discusses selecting patients with ovarian cancer for primary debulking surgery versus neoadjuvant chemotherapy.
Dr. Cosgrove on the Approval of Niraparib in Advanced Ovarian Cancer
January 24, 2020
Video
Casey M. Cosgrove, MD, discusses the approval of niraparib in advanced ovarian cancer.
Dr. Brammer on the Transformation of Stem Cell Transplant in ALL
January 24, 2020
Video
Jonathan E. Brammer, MD, discusses the progression of transplant in acute lymphoblastic leukemia.
Novel Regimens Generate Excitement in Lymphoma Treatment Paradigms
January 23, 2020
Article
Narendranath Epperla, MD, MS, reflects on recent advances in Hodgkin lymphoma and non-Hodgkin lymphoma.
Dr. Backes on Toxicity Considerations With PARP Inhibitors in Ovarian Cancer
January 23, 2020
Video
Floor J. Backes, MD, discusses toxicity considerations with PARP inhibitors in ovarian cancer.
Dr. Mims on the Emergence of Targeted Therapy in AML
January 22, 2020
Video
Alice S. Mims, MD, discusses the emergence of targeted therapy in acute myeloid leukemia treatment.
Dr. Copeland on the Role of Chemotherapy in Ovarian Cancer
January 18, 2020
Video
Larry J. Copeland, MD, discusses the role of chemotherapy in ovarian cancer.
Dr. Chaudhry on Novel Treatment Regimens in Relapsed/Refractory Multiple Myeloma
January 16, 2020
Video
Maria Chaudhry, MBBS, a hematologist at The Ohio State University Comprehensive Cancer Center—James, discusses novel treatment regimens in relapsed/refractory multiple myeloma.
Dr. Hays on Immunotherapy in Ovarian Cancer Treatment
January 15, 2020
Video
John Hays, MD, PhD, discusses the progression of immunotherapy in treating patients with ovarian cancer.
Dr. Mims on Developed Mutations in AML
January 15, 2020
Video
Alice S. Mims, MD, discusses developed resistance in acute myeloid leukemia.
Dr. Woyach on Ongoing Research With BTK Inhibitors in CLL
January 14, 2020
Video
Jennifer Woyach, MD, associate professor, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center–James, discusses ongoing research with BTK inhibitors in chronic lymphocytic leukemia (CLL).
OSUCCC-James Oncologists Share Ongoing Research Efforts in Hematologic Malignancies
January 11, 2020
Article
Experts from The Ohio State University Comprehensive Cancer Center–James highlighted exciting research being conducted at their institution.
Dr. Backes on Financial Toxicity Considerations in Ovarian Cancer
January 10, 2020
Video
Floor J. Backes, MD, discusses the consideration of financial toxicity when choosing a PARP inhibitor for a patient with ovarian cancer.
Dr. Brammer on the Importance of MRD in Relapsed/Refractory ALL
January 10, 2020
Video
Jonathan E. Brammer, MD, discusses the importance of achieving minimal residual disease negativity in relapsed/refractory acute lymphoblastic leukemia.
Targeted Therapy Approvals Spur Increased Biomarker Research in AML
January 09, 2020
Article
Alice Mims, MD, discusses biomarker research and therapeutic developments in acute myeloid leukemia.
Dr. Backes on the FILM Trial in Endometrial Cancer
January 09, 2020
Video
Floor J. Backes, MD, discusses the phase III FILM trial in endometrial cancer.
Relapsed/Refractory ALL Paradigm Rapidly Evolving With Novel Agents
January 09, 2020
Article
Jonathan E. Brammer, MD, discusses the role of minimal residual disease and transplant in acute lymphoblastic leukemia, as well as the introduction of CAR T-cell therapy and other novel agents to the armamentarium.
Dr. Mims on Performing Molecular Profiling at Diagnosis in AML
January 09, 2020
Video
Alice S. Mims, MD, discusses up front molecular profiling in patients with newly diagnosed acute myeloid leukemia.
Dr. Chaudhry on Unmet Needs in Relapsed/Refractory Multiple Myeloma
January 09, 2020
Video
Maria Chaudhry, MBBS, discusses unmet needs in relapsed/refractory multiple myeloma.
Woyach Highlights Progress and Next Steps in CLL Paradigm
January 08, 2020
Article
Jennifer A. Woyach, MD, discusses the evolving treatment paradigm and sequencing challenges in chronic lymphocytic leukemia.